NCT06487858 2026-03-18
A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors
BeOne Medicines
Phase 1 Active not recruiting
BeOne Medicines
Anhui Provincial Cancer Hospital
Eisai Inc.
Gilead Sciences
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
NEC Bio B.V